Samaneh Sardashti

Torbat Heydarieh University of Medical Sciences

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Rasool Raznahan

Iranshahr University

Reza Ghasemi

University of Qom

Mostafa Kamali

Torbat Heydarieh University of Medical Sciences

Hamideh Yaghoobi

Iranshahr University

Tahere Sarboozi Hosein Abadi

Birjand University of Medical Sciences

Saeed Reza Ghanbarizadeh

Shahid Beheshti University of Medical Sciences

Seddigheh Abbaspour

Torbat Heydarieh University of Medical Sciences

Hossein Dinpanah

Mashhad University of Medical Sciences

Sahar Mohammadi

Tehran University of Medical Sciences

Tahere Sarboozi Hossein-Abadi

Torbat Heydarieh University of Medical Sciences

Cooperative Institutions

Torbat Heydarieh University of Medical Sciences

Iranshahr University

Mashhad University of Medical Sciences

Iran University of Medical Sciences

Hormozgan University of Medical Sciences

Shahid Beheshti University of Medical Sciences

Shiraz University of Medical Sciences

University of Qom

Washington University in St. Louis

Institute for Research in Fundamental Sciences

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Investigation the effect of oral Aloe Vera gel pills supplementation on the intensity of primary menstrual pain (Dysmenorrhea)

Balneo Research Journal (2020)

Samaneh Sardashti Tahere Sarboozi Hosein Abadi Shoaib Sarboozi Hosein Abadi Rasool Raznahan

Introduction.This study was conducted to evaluate the effects of oral aloe vera gel pills supplementation on the intensity of menstrual pain.A randomized, single-blind clinical experimental plan was conducted amongst 150 single students aged 20 to 26 years who suffered from menstrual pain, at the Islamic Azad University of Medical Sciences from December 24, 2015 to October 22, 2016.The extent of pain was evaluated using the Cox Menstrual Symptom Scale (CMSC).Material and method.Each participant was randomly assigned to aloe vera gel pill or the anti-PG drug Ibuprofen, ending with 60 participants in each group equally.The first trial group received 10 mg of aloe vera gel orally four times daily until the pain grade reached one or less.The control group received Ibuprofen and three tablets orally three times a day.The participants were permitted to take another drug that they usually took for their pain relief, in addition to the allocated treatment in case of continued pain.At the end of the trial, these participants were excluded in data analysis.Results and discussions.Changes in the grade and the duration of the pain of participants were compared at the first and second months in both groups.Sample size was computed using α = 5% and absolute error equal to 0.24 for correlation between medication and pain with acceptable absolute precision formula (AAPF).Result of this study showed that the mean age was 22.1±1.4and20.4±1.2 years in aloe vera gel pills and Ibuprofen groups, respectively.No significant difference was observed for the matched characteristics studied between the treated groups.the mean pain grade amongst aloe vera group was decreased from 2.81±0.65 to 2.02±0.34,while in Ibuprofen group from 2.48 ± 0.4 to 1.32 ± 0.15, respectively, using the described given dose.As result obtained that there was no statistically significant decrease in pain duration for the women who received Ibuprofen compared to those who used aloe vera.Also there was no significant difference in pain grade between the groups at the second month of intervention (p=0.61).Pain duration at the second month of trial was similar between the both groups (p=0.76).Conclusions.In conclusion we could suggest that aloe vera gel pill as a novel herbal pain killer represents an effective treatment for the menstrual pain with no important side effects, although further clinical trials are recommended to look at the possible side effects in an extended spectrum of subjects.

Aloe Vera

Pill

Intensity

Menstruation

10.12680/balneo.2020.326

Cite

Citations (0)

Quetiapine versus Haloperidol in Controlling Conversion Disorder Symptoms; a Randomized Clinical Trial.

DOAJ (DOAJ: Directory of Open Access Journals) (2018)

Saeed Reza Ghanbarizadeh Hossein Dinpanah Reza Ghasemi Yaser Salahshour Samaneh Sardashti

About 5% of visits to emergency departments are made up of conversion disorder cases. This study was designed with the aim of comparing the effectiveness of quetiapine and haloperidol in controlling conversion disorder symptoms.The present single-blind clinical trial has been performed on patients with conversion disorder (based on the DSM-IV definition) presenting to emergency department of 9-Day Hospital, Torbat Heydariyeh, Iran, from January 2017 until May 2018.73 patients were allocated to haloperidol and 71 to quetiapine group. Mean age of these patients was 32.03 ± 12.80 years (62.50% female). Two groups were similar regarding the baseline characteristics. Within 30 minutes, 90.41% of haloperidol cases and 91.55% of quetiapine cases were relieved (p=0.812). The most common side effects after 30 minutes were extrapyramidal symptoms (9.59%) in the haloperidol group and fatigue and sleepiness (7.04%) in the quetiapine group. Extrapyramidal symptoms was significantly higher than the quetiapine group (p=0.013).The results of the present study showed that although quetiapine and haloperidol have a similar effect in relieving the patients from conversion disorder symptoms, the prevalence of extrapyramidal symptoms is significantly lower in the group under treatment with quetiapine. Therefore, it seems that quetiapine is a safer drug compared to haloperidol.

Extrapyramidal symptoms

Quetiapine Fumarate

Source

Cite

Citations (1)

Comparison of the Effect of Aerobic and Resistance Training on Cardiovascular Risk Factors in Parkinson's Women

The Open Nursing Journal (2019)

Hamideh Yaghoobi Sahar Mohammadi Samaneh Sardashti Seddigheh Abbaspour Tahere Sarboozi Hossein-Abadi

Background: People with low-mobility are at increased risk for cardiovascular disease. Patients with Parkinson's Disease (PD) are less interested in participating in exercise activities due to the nature of the disease. Regular exercise and physical activity can play protective roles against heart disease by reducing risk factors. This study aimed to compare the effects of aerobic and resistance training on cardiovascular risk factors in women with PD. Materials and Methods: This quasi-experimental study was carried out on 45 women with PD who were randomly assigned to one of three groups: aerobic, resistance groups, and control group. Before and after training sessions, variables of weight, Body Mass Index (BMI), heart rate at rest state, maximum oxygen consumption, blood pressure, and lipid profiles of participants were measured. Data were analyzed using SPSS software version 21 and Paired Sample t-test, ANOVA and Bonferroni post-hoc test. A significant level of P≤0.05 was considered. Results: Demographics of physiological characteristics of subjects was congruent in all three groups in the baseline. After aerobic and resistance training, levels of triglyceride, LDL, total cholesterol, fat percentage, resting heart rate, weight, BMI and systolic blood pressure were significantly decreased (p<0.05). This change was more pronounced in the aerobic group; in contrast, variables of maximum oxygen consumption and HDL were meaningfully increased in participants of both experimental groups (p<0.05). Conclusion: The results showed that both types of aerobic and resistance training can reduce the risk factors of cardiovascular disease in women with PD, while the effect of aerobic training on reducing risk factors was more than resistance training.

Aerobic Exercise

Demographics

Post-hoc analysis

Lipid Profile

10.2174/1874434601913010186

Cite

Citations (3)